首页> 外文期刊>The biochemical journal >The inactive MoFe protein (NifB?Kp1) of the nitrogenase from nif B mutants of Klebsiella pneumoniae. Its interaction with FeMo-cofactor and the properties of the active MoFe protein formed
【24h】

The inactive MoFe protein (NifB?Kp1) of the nitrogenase from nif B mutants of Klebsiella pneumoniae. Its interaction with FeMo-cofactor and the properties of the active MoFe protein formed

机译:肺炎克雷伯氏菌nif B突变体中的固氮酶的非活性MoFe蛋白(NifB?Kp1)。它与FeMo辅因子的相互作用以及形成的活性MoFe蛋白的性质

获取原文
           

摘要

pThe inactive MoFe protein (NifB-Kp1) of nitrogenase from nifB mutants of Klebsiella pneumoniae may be activated by addition of the iron-molybdenum cofactor (FeMoco) extracted from active MoFe protein (Kp1). However, when apparently saturated with FeMoco, our preparations of NifB-Kp1 yielded activated protein, Kp1-asm, with a specific activity that was at best only 40% of that expected. This was not due to degradation of Kp1-asm, NifB-Kp1 or FeMoco during the activation reaction. Nor could activation be enhanced by addition of other nif-gene products or other proteins. Whereas fully active Kp1 contains 2 FeMoco/molecule, apparent saturation of our NifB-Kp1 preparations required the binding of only 0.4-0.65 FeMoco/molecule. By using chromatography Kp1-asm could be largely resolved from NifB-Kp1 that had not been activated. However, we were unable to isolate fully active MoFe protein (i.e. Kp1-asm containing 2 FeMoco/molecule) from solutions of NifB-Kp1 activated with FeMoco. The maximum activityg-atom of total Mo obtained for our purified Kp1-asm was approximately half the maximum activity for FeMoco. Since all NifB-Kp1 preparations contained some Mo, we suggest that FeMoco activated only those NifB-Kp1 molecules already containing one atom of (non-FeMoco) Mo, thus forming Kp1-asm with 2 Mo but only 1 FeMoco/molecule. Kp1-asm was identical with normal Kp1 in terms of its Mr, stability, e.p.r. signals, pattern of substrate reductions, CO inhibition and ATP/2e ratio. In addition, for preparations of differing specific activity, there was a constant and identical relationship between the e.p.r. signal intensity (from FeMoco) and the activity of both Kp1 and Kp1-asm. Assuming the above hypothesis on the structure of Kp1-asm, these data demonstrate that the two FeMoco sites in wild-type Kp1 operate independently./p
机译:>通过添加从活性MoFe蛋白(Kp1)中提取的铁-钼辅因子(FeMoco),可以激活肺炎克雷伯菌nifB突变体中固氮酶的非活性MoFe蛋白(NifB-Kp1)。但是,当显然用FeMoco饱和时,我们的NifB-Kp1制剂会产生活化蛋白Kp1-asm,其比活性最多仅为预期的40%。这不是由于活化反应过程中Kp1-asm,NifB-Kp1或FeMoco的降解。添加其他nif基因产物或其他蛋白质也无法增强激活作用。完全活性的Kp1包含2 FeMoco /分子,而我们的NifB-Kp1制剂的表观饱和仅需要结合0.4-0.65 FeMoco /分子。通过使用色谱法,可以将Kp1-asm从尚未活化的NifB-Kp1中分离出来。但是,我们无法从FeFeco活化的NifB-Kp1溶液中分离出完全活性的MoFe蛋白(即,含有2个FeMoco /分子的Kp1-asm)。我们纯化的Kp1-asm所获得的总Mo的最大活性/ ng原子约为FeMoco的最大活性的一半。由于所有NifB-Kp1制剂均含有一些Mo,因此我们建议FeMoco仅激活已经包含一个(非FeMoco)Mo原子的NifB-Kp1分子,从而与2 Mo形成Kp1-asm,但仅使FeFeco /分子达到1。 Kp1-asm的Mr,稳定性,e.p.r与正常Kp1相同。信号,底物还原模式,CO抑制和ATP / 2e比。另外,对于具有不同比活性的制剂,其e.p.r.之间存在恒定且相同的关系。信号强度(来自FeMoco)以及Kp1和Kp1-asm的活性。假设以上关于Kp1-asm结构的假设,这些数据表明野生型Kp1中的两个FeMoco位点是独立运行的。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号